Lam, Kin

Lam, Kin was paid $770K by Medicaid between Jan 2018 and Nov 2024, across 93 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 46% of everything it billed.

33Billing provider infoLAM, KIN
NEW YORK, NY 10013

33aNPI1962442699assigned 06/08/2006

33bProvider typeHematology & Oncology Physician

28Total paid$770K

24GClaims75,515

24DCodes billed93

24AFirst – last monthJan 2018 – Nov 2024

Compared with peers

Next to other Hematology & Oncology Physician providers in New York

Rank by total paid#19 of 441

Median peer was paid$9K

This provider vs. median81×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	2,210	$68K
2019	3,673	$79K
2020	5,022	$101K
2021	12,151	$158K
2022	14,197	$133K
2023	20,347	$122K
2024incomplete	17,915	$109K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	46%	10,415	8,439	$356K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	28%	5,653	4,612	$219K
99442		10%	1,698	1,484	$79K
99490	Ccm add 20min	7.7%	3,637	3,629	$59K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.4%	401	285	$10K
99497		1.2%	913	900	$9K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	453	375	$7K
99443		<1%	71	64	$4K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	<1%	85	85	$3K
99439		<1%	282	281	$3K
96127		<1%	725	708	$2K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	597	476	$2K

81 more codes

90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	279	$2K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	1,518	$2K
96375	Therapeutic injection; each additional sequential IV push	<1%	113	$1K
36415	Collection of venous blood by venipuncture	<1%	3,542	$1K
93000		<1%	274	$1K
94010		<1%	166	$1K
99397		<1%	318	$1K
99441		<1%	99	$988.20
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	59	$840.39
90678		<1%	13	$788.68
0011A		<1%	16	$639.78
90756		<1%	29	$580.24
90662		<1%	76	$574.49
99051		<1%	2,052	$489.69
G0444	Annual depression screening, 5 to 15 minutes	<1%	638	$308.12
90686		<1%	26	$293.75
99401		<1%	100	$288.59
G8510	Screening for depression is documented as negative, a follow-up plan is not required	<1%	362	$231.58
G9622	Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method	<1%	241	$215.00
99491	Ccm add 20min	<1%	14	$193.40
G0442	Annual alcohol misuse screening, 5 to 15 minutes	<1%	283	$170.00
H0001	Alcohol and/or drug assessment	<1%	40	$153.00
90653		<1%	102	$133.26
J1626	Injection, granisetron hydrochloride, 100 mcg	<1%	154	$97.48
90688		<1%	27	$86.24
J7050	Infusion, normal saline solution, 250 cc	<1%	346	$40.60
90694		<1%	172	$39.45
3078F		<1%	5,165	$36.70
3074F		<1%	3,849	$35.00
1160F		<1%	1,374	$30.78
G8420	Bmi is documented within normal parameters and no follow-up plan is required	<1%	1,618	$27.00
3079F		<1%	1,511	$25.00
3077F		<1%	1,527	$25.00
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	137	$23.66
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	95	$22.85
1159F		<1%	3,961	$20.58
G8754	Most recent diastolic blood pressure < 90 mmhg	<1%	2,141	$15.00
G8752	Most recent systolic blood pressure < 140 mmhg	<1%	1,782	$11.00
81002		<1%	33	$5.08
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	28	$3.79
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	16	$3.68
1170F		<1%	171	$1.70
1158F		<1%	389	$1.70
G8753	Most recent systolic blood pressure >= 140 mmhg	<1%	319	$1.00
3044F		0%	381	$0.00
1036F		0%	156	$0.00
2000F		0%	4,241	$0.00
1101F		0%	145	$0.00
3048F		0%	323	$0.00
G8419	Bmi documented outside normal parameters, no follow-up plan documented, no reason given	0%	405	$0.00
3008F		0%	4,777	$0.00
4010F		0%	14	$0.00
G0008	Administration of influenza virus vaccine	0%	335	$0.00
3075F		0%	1,564	$0.00
99429		0%	399	$0.00
1000F		0%	40	$0.00
36416		0%	81	$0.00
0134A		0%	13	$0.00
G0136	Administration of a standardized, evidence-based assessment of physical activity and nutrition, 5-15 minutes, not more often than every 6 months	0%	26	$0.00
1157F		0%	78	$0.00
3080F		0%	78	$0.00
1126F		0%	37	$0.00
4037F		0%	247	$0.00
1125F		0%	12	$0.00
G8755	Most recent diastolic blood pressure >= 90 mmhg	0%	26	$0.00
0064A		0%	12	$0.00
3016F		0%	144	$0.00
3051F		0%	69	$0.00
G0446	Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes	0%	143	$0.00
G9507	Documentation that the patient is on a statin medication or has documentation of a valid contraindication or exception to statin medications; contraindications/exceptions that can be defined by diagnosis codes include pregnancy during the measurement period, active liver disease, rhabdomyolysis, end stage renal disease on dialysis and heart failure; provider documented contraindications/exceptions include breastfeeding during the measurement period, woman of child-bearing age not actively taking birth control, allergy to statin, drug interaction (hiv protease inhibitors, nefazodone, cyclosporine, gemfibrozil, and danazol) and intolerance (with supporting documentation of trying a statin at least once within the last 5 years or diagnosis codes for myostitis or toxic myopathy related to drugs)	0%	136	$0.00
3725F		0%	173	$0.00
3288F		0%	338	$0.00
G8427	Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications	0%	400	$0.00
G8476	Most recent blood pressure has a systolic measurement of < 140 mmhg and a diastolic measurement of < 90 mmhg	0%	18	$0.00
G8482	Influenza immunization administered or previously received	0%	64	$0.00
G8417	Bmi is documented above normal parameters and a follow-up plan is documented	0%	214	$0.00
90682		0%	24	$0.00
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	0%	151	$0.00
99072		0%	109	$0.00
S0028	Injection, famotidine, 20 mg	0%	24	$0.00
G9919	Screening performed and positive and provision of recommendations	0%	13	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.